CORT CIK: 1088856

Corcept Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
168
FY22:
120
FY23:
127
FY24:
198
FY25:
142
Change from FY21 to FY25
millions USD
FY21:
136
FY22:
−114
FY23:
90.9
FY24:
−178
FY25:
69.8
Change from FY21 to FY25
millions USD
FY21:
−303
FY22:
−17.3
FY23:
−149
FY24:
−28.3
FY25:
−220
millions USD
FY21:
1.43
FY22:
−11.3
FY23:
69.2
FY24:
−7.89
FY25:
−7.17
(positive)
Change from FY21 to FY25
millions USD
FY21:
167
FY22:
120
FY23:
127
FY24:
196
FY25:
142

All amounts in millions USD Data source:SEC EDGAR